CD86 and neoplasm: observed the expansion of CTLA4+PD-1− T cells close to CD86+ tumor cells and tumor-associated macrophages (39), which suggests that the interaction between CD86 and CTLA4 might be a key negative regulator in Hodgkin lymphoma.